This inventor holds 1 USPTO granted patent and 1 published patent application. Top assignees: Novartis Ag, Surface Oncology, Inc.. Active years: 2022.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
1 out of 3,978 
1 out of 13 
Years Active: 2022
Title: Mikias Woldegiorgis: Innovator in Cancer Treatment
Introduction
Mikias Woldegiorgis is a prominent inventor based in Oakland, CA. He has made significant contributions to the field of cancer treatment through his innovative research and development of antibody molecules.
Latest Patents
Woldegiorgis holds a patent for "Antibody molecules to CD73 and uses thereof." This patent discloses antibody molecules that bind to CD73, which can be utilized to treat, prevent, and diagnose cancer. His work in this area is crucial for advancing therapeutic options for patients.
Career Highlights
Throughout his career, Mikias has worked with notable companies such as Novartis AG and Surface Oncology, Inc. His experience in these organizations has allowed him to develop and refine his expertise in the biotechnology sector.
Collaborations
Mikias has collaborated with talented individuals in his field, including Bianka Prinz and Jerry M. Thomas. These partnerships have contributed to the success of his projects and the advancement of cancer research.
Conclusion
Mikias Woldegiorgis is a dedicated inventor whose work in antibody development is paving the way for new cancer treatments. His innovative spirit and collaboration with industry leaders highlight his commitment to improving patient outcomes.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile